Eprosartan
Teveten (eprosartan) is a small molecule pharmaceutical. Eprosartan was first approved as Teveten on 1997-12-22. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against type-1 angiotensin II receptor.
| Trade Name | Teveten |
|---|---|
| Common Name | Eprosartan |
| Indication | diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction |
| Drug Class | Angiotensin II receptor antagonists |
